Stockscreener 앱 받기
5.7957
2.84%
0.1657
Cvrx Inc 주식(CVRX)의 최신 뉴스
(CVRX) Risk Channels and Responsive Allocation - Stock Traders Daily
Enterprise value to EBIT forward of CVRx, Inc. – NASDAQ:CVRX - TradingView
CVRX,INVA Volatility & Greeks - Finviz
CVRx shares rise on CMS inclusion for Barostim implant procedure - MSN
CVRx (CVRX) Moves 11.6% Higher: Will This Strength Last? - Yahoo Finance
Price to earnings forward of CVRx, Inc. – NASDAQ:CVRX - TradingView
Enterprise value to revenue forward of CVRx, Inc. – NASDAQ:CVRX - TradingView
Price to book forward of CVRx, Inc. – NASDAQ:CVRX - TradingView
CVRx, Inc. Actuals & Estimates (NASDAQ:CVRX) - TradingView
CVRX Forecast — Price Target — Prediction for 2027 - TradingView
(CVRX) Movement as an Input in Quant Signal Sets - Stock Traders Daily
CVRx Inc (CVRX) Institutional Confidence - TradingKey
CVRx stock up on Humana's Medicare coverage for Barostim therapy - MSN
CVRx Inc (CVRX) Stock Forecast & Analyst Ratings - Moomoo
CVRx Inc (CVRX) Valuation: PE, PB & Fair Value Analysis - TradingKey
CVRx Inc (CVRX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
CVRx to present Barostim integration strategies at AAHFN Annual Meeting - Traders Union
CVRx Inc (CVRX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
CVRx Inc (CVRX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
CVRx Inc (CVRX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
CVRx Inc (CVRX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CVRx Inc (CVRX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
CVRx Inc (CVRX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Barostim adoption in heart failure management advances, led by CVRx - Traders Union
CVRX Q1 2026 Earnings: EPS Beat Slightly Narrows LossReturn On Assets - dars.gov.et
Analysts Offer Insights on Healthcare Companies: CVRx (CVRX) and Context Therapeutics (CNTX) - The Globe and Mail
CVRX: CFO transition, expanded clinical trials, and improved reimbursement drive growth and adoption - TradingView
CVRX: CFO transition, strong Q1 growth, and expanded reimbursement drive U.S. market momentum - TradingView
CVRx CFO Jared Oasheim to step down after decade with company By Investing.com - Investing.com Australia
Craig-Hallum Maintains CVRx Inc(CVRX.US) With Buy Rating - Moomoo
CVRx Announces CFO Jared Oasheim’s Departure and Launches Search for Successor - Minichart
CVRx CFO Jared Oasheim to step down - MSN
CVRx CFO Jared Oasheim to step down after decade with company - Investing.com Australia
CVRx CFO Jared Oasheim to Resign, Will Stay Through Transition and Serve as Consultant - TradingView
Jared Oasheim to Resign as Chief Financial Officer of CVRx, Inc - marketscreener.com
[8-K] CVRx, Inc. Reports Material Event - Stock Titan
CVRx Announces Chief Financial Officer Transition - The Globe and Mail
CVRx Chief Financial Officer Jared Oasheim Leaving - Moomoo
Medical device firm CVRx plans CFO change, keeps him through Feb. 2027 - Stock Titan
CVRx, Inc. (CVRX) Presents at 46th Annual William Blair Growth Stock ConferenceSlideshow - Seeking Alpha
CVRx (NASDAQ: CVRX) director Nielsen awarded shares and 11,182-share option - Stock Titan
CVRx, Inc. (CVRX) director receives new share and option grants - Stock Titan
[Form 4] CVRx, Inc. Insider Trading Activity - Stock Titan
CVRx (CVRX) director granted 8,720 shares and options for 11,182 - Stock Titan
CVRx (CVRX) director receives new share and stock option awards - Stock Titan
Martha Shadan of CVRx, Inc. (CVRX) receives stock and option grants - Stock Titan
CVRx, Inc. (CVRX) director granted shares and stock options - Stock Titan
[Form 3] CVRx, Inc. Initial Statement of Beneficial Ownership - Stock Titan
William Blair Maintains CVRx Inc(CVRX.US) With Buy Rating - 富途牛牛
CVRx (CVRX) investors re-elect directors and ratify Grant Thornton as auditor - Stock Titan
CVRx, Inc. Elects Michael Dale as Director - marketscreener.com
Why (CVRX) Price Action Is Critical for Tactical Trading - Stock Traders Daily
CVRX: Barostim drives heart failure innovation with strong clinical results and expanding market access - TradingView
CVRX: Barostim's clinical success and new Humana coverage drive expanded heart failure market access - TradingView
CVRXCVRx Inc Forecast, Target Price - Finviz
CVRx to present at Goldman Sachs Healthcare Con... | Pluang – Crypto, Stocks, Gold & Funds - Pluang
CVRx to Present at the Goldman Sachs 47th Annual Global Healthcare Conference - marketscreener.com
CVRx Inc. (CVRX) Slips 1.04% as Stock Hovers Near Key Support ZoneMean Reversion Trade - thelegaladvocate.com
0.14%
1.00%
자본화:
|
볼륨(24시간):